M. Baskurt Et Al. , "N-acetylcysteine versus N-acetylcysteine plus theophylline for the prevention of contrast nephropathy," EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , vol.39, no.9, pp.793-799, 2009
Baskurt, M. Et Al. 2009. N-acetylcysteine versus N-acetylcysteine plus theophylline for the prevention of contrast nephropathy. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , vol.39, no.9 , 793-799.
Baskurt, M., Okcun, B., Abaci, O., Dogan, G. M., Kilickesmez, K., Özkan, A., ... Ersanli, M.(2009). N-acetylcysteine versus N-acetylcysteine plus theophylline for the prevention of contrast nephropathy. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , vol.39, no.9, 793-799.
Baskurt, M. Et Al. "N-acetylcysteine versus N-acetylcysteine plus theophylline for the prevention of contrast nephropathy," EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , vol.39, no.9, 793-799, 2009
Baskurt, M. Et Al. "N-acetylcysteine versus N-acetylcysteine plus theophylline for the prevention of contrast nephropathy." EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , vol.39, no.9, pp.793-799, 2009
Baskurt, M. Et Al. (2009) . "N-acetylcysteine versus N-acetylcysteine plus theophylline for the prevention of contrast nephropathy." EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , vol.39, no.9, pp.793-799.
@article{article, author={M. Baskurt Et Al. }, title={N-acetylcysteine versus N-acetylcysteine plus theophylline for the prevention of contrast nephropathy}, journal={EUROPEAN JOURNAL OF CLINICAL INVESTIGATION}, year=2009, pages={793-799} }